Treatment with soluble CD24 attenuates COVID-19-associated systemic immunopathology
Published in Journal of Hematology & Oncology, 2022
Abstract Background Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19) through direct lysis of infected lung epithelial cells, which releases damage-associated molecular patterns and induces a pro-inflammatory cytokine milieu causing systemic inflammation. Anti-vi…
Recommended citation: No‐Joon Song, Carter Allen, Anna E. Vilgelm, Brian Riesenberg, Kevin P. Weller, Kelsi Reynolds, Karthik B. Chakravarthy, Amrendra Kumar, et al.. (2022). "Treatment with soluble CD24 attenuates COVID-19-associated systemic immunopathology" Journal of Hematology & Oncology.
Download Paper